Product Information
ELETRIPTAN HBR 40 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.9092 per EA under NDC 59651010569. Its NADAC has been published 366 times since Aug 21, 2019.
FDA first approved this application on Jan 15, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651010569
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ELETRIPTAN HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210708FDA Approved
1/15/2019
TE Code
AB
On Market Since
2/16/2018
Pharmacological Classes
Price Statistics
The NADAC for ELETRIPTAN HBR 40 MG TABLET has been published 366 times since Aug 21, 2019, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9092 per EA |
|---|---|
| All-time high | $6.7649 (Dec 11, 2019) |
| All-time low | $1.7938 (Apr 22, 2026) |
| 52-week high | $2.1601 |
| 52-week low | $1.7938 |
| Median price | $3.0581 |
| Average price | $3.6146 |
| Largest weekly change | +40.6% (Nov 22, 2023) |
| Weeks tracked | 366 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ELETRIPTAN HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ELETRIPTAN HBR 40 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.9092 per EA (NDC 59651010569), effective Aug 19, 2026.
How has the price of ELETRIPTAN HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ELETRIPTAN HBR 40 MG TABLET has declined 69.8%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for ELETRIPTAN HBR 40 MG TABLET?
Since Aug 21, 2019, the NADAC for ELETRIPTAN HBR 40 MG TABLET has ranged from a low of $1.7938 (Apr 22, 2026) to a high of $6.7649 (Dec 11, 2019), with a median of $3.0581 per EA.
Are there cheaper alternatives to ELETRIPTAN HBR 40 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ELETRIPTAN HBR 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ELETRIPTAN HBR 40 MG TABLET?
ELETRIPTAN HBR 40 MG TABLET (NDC 59651010569) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.